Mireia De Oliveira Correia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Mireia De Oliveira Correia has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Tiago Lima Sampaio
Universidade Federal do Ceará
5 shared publications - Afonso Leoncio Saraiva Junior
Universidade Federal do Ceará
2 shared publications - Ana Beatriz Silva Lima2 shared publications
- Antonia Gabriella de Souza Freitas
Universidade Federal do Ceará
2 shared publications - Vanessa Gonzaga Da Silva Gomes
Universidade Federal do Ceará
2 shared publications - Ana Caroline Borges Lima1 shared publication
Latest Publications
- Open Access
- 31 March 2025
- Published by Universidade Federal do Ceará (UFC) in Medicinae Plantae
- Vol. 2, e97163
Terapia Hormonal de Transição de Gênero: Revisão Integrativa
Transgender (transgender) people are those whose gender identity differs from their birth sex. A significant portion of trans people seek Gender Affirming Hormone Therapy (GAHT) to align their physical characteristics with their gender identity. This integrative literature review aimed to provide an overview of medications used in GHA in trans women and men, based on primary studies published between 2020 and 2025 in three databases and in the International Journal of Transgenderism. After using the search strategy and applying the inclusion and exclusion criteria, 12 articles were selected for analysis. The results were grouped into categories: GHAHT clinical efficacy; safety and adverse effects; metabolic and bodily changes; psychosocial and behavioral impacts; and adherence to and compliance with clinical guidelines. The use of GHAHT emerges as an auxiliary tool for the gender affirmation process, providing congruence between gender identity and body image, with direct impacts on the mental health and well-being of these individuals. Several studies indicate changes in body composition and metabolic markers. Regular monitoring of adverse effects, particularly those related to hematological and cardiovascular parameters, is necessary, as well as studies of the long-term effects of THAG.
- 31 March 2025
- Published by Universidade Federal do Ceará (UFC) in Medicinae Plantae
- Vol. 2, e97163
Open AccessTerapia Hormonal de Transição de Gênero: Revisão Integrativa
Transgender (transgender) people are those whose gender identity differs from their birth sex. A significant portion of trans people seek Gender Affirming Hormone Therapy (GAHT) to align their physical characteristics with their gender identity. This integrative literature review aimed to provide an overview of medications used in GHA in trans women and men, based on primary studies published between 2020 and 2025 in three databases and in the International Journal of Transgenderism. After using the search strategy and applying the inclusion and exclusion criteria, 12 articles were selected for analysis. The results were grouped into categories: GHAHT clinical efficacy; safety and adverse effects; metabolic and bodily changes; psychosocial and behavioral impacts; and adherence to and compliance with clinical guidelines. The use of GHAHT emerges as an auxiliary tool for the gender affirmation process, providing congruence between gender identity and body image, with direct impacts on the mental health and well-being of these individuals. Several studies indicate changes in body composition and metabolic markers. Regular monitoring of adverse effects, particularly those related to hematological and cardiovascular parameters, is necessary, as well as studies of the long-term effects of THAG.
- Open Access
- 22 January 2025
- Published by Instituto para o Desenvolvimento da Educacao in Journal of Health & Biological Sciences
- Vol. 13 (1) , e5771
Efeito da imunossupressão sobre a atividade de enzimas de avaliação da função hepática pós-transplante renal em hospital universitário de Fortaleza
Objetivo: avaliar as alterações nas enzimas hepáticas em pacientes submetidos a transplante renal, comparando dois regimes imunossupressores diferentes. Métodos: foi conduzido um estudo retrospectivo envolvendo 186 pacientes que realizaram transplante renal entre 2019 e 2023 no Hospital Universitário Walter Cantídio (HUWC). Os pacientes foram divididos em dois grupos, conforme o regime imunossupressor utilizado: Tacrolimus e Micofenolato de Sódio (TAC+MDS) e Tacrolimus e Sirolimus (TAC+SRL). As atividades das enzimas alanina transaminase (ALT), aspartato transaminase (AST) e gama-glutamil transferase (GGT) foram analisadas e categorizadas quanto ao perfil da elevação acima do valor de referência. Resultados: os dois grupos de imunossupressão apresentaram mais de 50% de casos de aumento nos parâmetros de função hepática, porém sem diferença significativa. Apenas o grupo TAC+SRL apresentou elevações significativas nos níveis de GGT (p = 0.038; OR = 9.75; IC95% = 0.531 - 179), indicando uma potencial maior hepatotoxicidade associada ao regime TAC+SRL. Conclusões: os regimes imunossupressores estão associados a uma elevação subclínica das enzimas hepáticas, sem diferença significativa entre ambas. Contudo, a combinação de Tacrolimus e Sirolimus apresenta uma correlação com uma elevação grave da enzima hepática GGT, porém a grande variabilidade no intervalo de confiança sugere uma análise de baixa precisão devido a amostra pequena, sendo necessário análises mais robustas para confirmar essa suspeita. risco aumentado de hepatotoxicidade. Esses achados ressaltam a importância do monitoramento rigoroso e contínuo da função hepática em pacientes que recebem esse regime após o transplante renal, para a detecção precoce e o manejo apropriado das complicações hepáticas.
- 22 January 2025
- Published by Instituto para o Desenvolvimento da Educacao in Journal of Health & Biological Sciences
- Vol. 13 (1) , e5771
Open AccessEfeito da imunossupressão sobre a atividade de enzimas de avaliação da função hepática pós-transplante renal em hospital universitário de Fortaleza
Objetivo: avaliar as alterações nas enzimas hepáticas em pacientes submetidos a transplante renal, comparando dois regimes imunossupressores diferentes. Métodos: foi conduzido um estudo retrospectivo envolvendo 186 pacientes que realizaram transplante renal entre 2019 e 2023 no Hospital Universitário Walter Cantídio (HUWC). Os pacientes foram divididos em dois grupos, conforme o regime imunossupressor utilizado: Tacrolimus e Micofenolato de Sódio (TAC+MDS) e Tacrolimus e Sirolimus (TAC+SRL). As atividades das enzimas alanina transaminase (ALT), aspartato transaminase (AST) e gama-glutamil transferase (GGT) foram analisadas e categorizadas quanto ao perfil da elevação acima do valor de referência. Resultados: os dois grupos de imunossupressão apresentaram mais de 50% de casos de aumento nos parâmetros de função hepática, porém sem diferença significativa. Apenas o grupo TAC+SRL apresentou elevações significativas nos níveis de GGT (p = 0.038; OR = 9.75; IC95% = 0.531 - 179), indicando uma potencial maior hepatotoxicidade associada ao regime TAC+SRL. Conclusões: os regimes imunossupressores estão associados a uma elevação subclínica das enzimas hepáticas, sem diferença significativa entre ambas. Contudo, a combinação de Tacrolimus e Sirolimus apresenta uma correlação com uma elevação grave da enzima hepática GGT, porém a grande variabilidade no intervalo de confiança sugere uma análise de baixa precisão devido a amostra pequena, sendo necessário análises mais robustas para confirmar essa suspeita. risco aumentado de hepatotoxicidade. Esses achados ressaltam a importância do monitoramento rigoroso e contínuo da função hepática em pacientes que recebem esse regime após o transplante renal, para a detecção precoce e o manejo apropriado das complicações hepáticas.
- Open Access
- 1 January 2024
- Published by Supervisão Clínica
The Potential Pharmacological Effect of the Monoclonal Antibody Donanemab in the Treatment of Alzheimer's Disease
Book Brazil in Advancing Pharmacotherapy and Clinical Pharmacy in Latin America Proceedings of the Fourth Brazilian Congress of Pharmacotherapy and Clinical Pharmacy doi: 10.62922/4cbffc ISBN: 978-65-983944-2-4 Editors Wallace Entringer Bottacin – ORCID | Lattes | Google Scholar Thaís Teles de Souza – ORCID | Lattes Walleri Christini Torelli Reis – ORCID | Lattes | Google […]
- 1 January 2024
- Published by Supervisão Clínica
Open AccessThe Potential Pharmacological Effect of the Monoclonal Antibody Donanemab in the Treatment of Alzheimer's Disease
Book Brazil in Advancing Pharmacotherapy and Clinical Pharmacy in Latin America Proceedings of the Fourth Brazilian Congress of Pharmacotherapy and Clinical Pharmacy doi: 10.62922/4cbffc ISBN: 978-65-983944-2-4 Editors Wallace Entringer Bottacin – ORCID | Lattes | Google Scholar Thaís Teles de Souza – ORCID | Lattes Walleri Christini Torelli Reis – ORCID | Lattes | Google […]
- Open Access
- 1 January 2024
- Published by Supervisão Clínica
Therapeutic Perspectives on the Use of Cannabis in the Management of Autism Spectrum Disorder (ASD)
Book Brazil in Advancing Pharmacotherapy and Clinical Pharmacy in Latin America Proceedings of the Fourth Brazilian Congress of Pharmacotherapy and Clinical Pharmacy doi: 10.62922/4cbffc ISBN: 978-65-983944-2-4 Editors Wallace Entringer Bottacin – ORCID | Lattes | Google Scholar Thaís Teles de Souza – ORCID | Lattes Walleri Christini Torelli Reis – ORCID | Lattes | Google […]
- 1 January 2024
- Published by Supervisão Clínica
Open AccessTherapeutic Perspectives on the Use of Cannabis in the Management of Autism Spectrum Disorder (ASD)
Book Brazil in Advancing Pharmacotherapy and Clinical Pharmacy in Latin America Proceedings of the Fourth Brazilian Congress of Pharmacotherapy and Clinical Pharmacy doi: 10.62922/4cbffc ISBN: 978-65-983944-2-4 Editors Wallace Entringer Bottacin – ORCID | Lattes | Google Scholar Thaís Teles de Souza – ORCID | Lattes Walleri Christini Torelli Reis – ORCID | Lattes | Google […]
- Open Access
- 1 January 2024
- Published by Supervisão Clínica
Sex Hormones as Therapeutic Targets in the Pathophysiology of Migraine
Book Brazil in Advancing Pharmacotherapy and Clinical Pharmacy in Latin America Proceedings of the Fourth Brazilian Congress of Pharmacotherapy and Clinical Pharmacy doi: 10.62922/4cbffc ISBN: 978-65-983944-2-4 Editors Wallace Entringer Bottacin – ORCID | Lattes | Google Scholar Thaís Teles de Souza – ORCID | Lattes Walleri Christini Torelli Reis – ORCID | Lattes | Google […]
- 1 January 2024
- Published by Supervisão Clínica
Open AccessSex Hormones as Therapeutic Targets in the Pathophysiology of Migraine
Book Brazil in Advancing Pharmacotherapy and Clinical Pharmacy in Latin America Proceedings of the Fourth Brazilian Congress of Pharmacotherapy and Clinical Pharmacy doi: 10.62922/4cbffc ISBN: 978-65-983944-2-4 Editors Wallace Entringer Bottacin – ORCID | Lattes | Google Scholar Thaís Teles de Souza – ORCID | Lattes Walleri Christini Torelli Reis – ORCID | Lattes | Google […]
- Open Access
- 1 January 2024
- Published by Supervisão Clínica
The Future of Modern Oncology Driven By Multifunctional Nanoparticles and Their Innovative Applications in Cancer Treatment
Book Brazil in Advancing Pharmacotherapy and Clinical Pharmacy in Latin America Proceedings of the Fourth Brazilian Congress of Pharmacotherapy and Clinical Pharmacy doi: 10.62922/4cbffc ISBN: 978-65-983944-2-4 Editors Wallace Entringer Bottacin – ORCID | Lattes | Google Scholar Thaís Teles de Souza – ORCID | Lattes Walleri Christini Torelli Reis – ORCID | Lattes | Google […]
- 1 January 2024
- Published by Supervisão Clínica
Open AccessThe Future of Modern Oncology Driven By Multifunctional Nanoparticles and Their Innovative Applications in Cancer Treatment
Book Brazil in Advancing Pharmacotherapy and Clinical Pharmacy in Latin America Proceedings of the Fourth Brazilian Congress of Pharmacotherapy and Clinical Pharmacy doi: 10.62922/4cbffc ISBN: 978-65-983944-2-4 Editors Wallace Entringer Bottacin – ORCID | Lattes | Google Scholar Thaís Teles de Souza – ORCID | Lattes Walleri Christini Torelli Reis – ORCID | Lattes | Google […]